3347.HK · TIGERMED
Hong Kong · RS rating 61 · As of 2026-10-14
| Price | 41.50 HKD |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 61 / 34 / 72 / 60 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 37 / 25 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.8% |
| Distance from 52-week high | +24.8% |
| Market cap (USD) | $4.9B |